|
The NIAMS gratefully acknowledges the assistance of the following
people in the preparation and review of this publication:
John H. Klippel, M.D., NIAMS, NIH; Reva Lawrence, M.P.H.,
NIAMS, NIH; Amye L. Leong, San Pedro Peninsula, California;
Michael D. Lockshin, M.D., Barbara Volcker Center for Women
and Rheumatic Disease, Hospital for Special Surgery, New York,
New York; Kate Lorig, R.N., Dr.P.H., Stanford University,
Stanford, California; J. Lee Nelson, M.D., Fred Hutchinson
Cancer Research Center, Seattle, Washington; Stanley R. Pillemer,
M.D., NIH; Paul H. Plotz, M.D., NIAMS, NIH; Paul G. Rochmis,
M.D., Fairfax, Virginia; and Ronald L. Wilder, M.D., Ph.D.,
NIAMS, NIH. Special thanks also go to Cheryl Yarboro, R.N.,
B.S.P.A., NIAMS, NIH, and to the patients who reviewed this
publication and provided valuable input. This booklet was
written by Anne Brown Rodgers of Cygnus Corporation.
About
NIAMS and NAMSIC
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Be sure to visit the Glucosamine Product Guide for a review of commercially available glucosamine products broken down by 9 different categories such as price per month, quality and type. Learn what the best products out there are and what criteria was used to ranked each.
|
